Prof Research published a new market report on imidazolidinone (ethylene urea). It presents the largest 8 manufacturers in imidazolidinone (ethylene urea) market. The report is a professional and in-depth study on the current state of the global imidazolidinone (ethylene urea) market with a focus on the Chinese market. The report provides key statistics on the market of imidazolidinone (ethylene urea). It is a valuable source of guidance and direction for companies and individuals interested in imidazolidinone (ethylene urea) industry.

The global imidazolidinone (ethylene urea) market was valued to be 28.37 million USD in 2020. The imidazolidinone (ethylene urea) production value is anticipated to have grown with a CAGR of 11.39% in the coming years to reach 54.20 million USD in 2026.

BASF is the largest manufacturer of imidazolidinone (ethylene urea) in the world, it has a market share of 64.05% in value. Its portfolio is divided into the Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care and Agricultural Solutions segments.

Hebei Kangzhuang is the second-largest manufacturer of imidazolidinone (ethylene urea) in the world, it has a market share of 10.51% in value. Its main products are: 2- imidazolidone (ethylene urea), 1, 3-dimethyl-2-imidazolidone (DMI), 1- (2-hydroxyethyl ) -2- imidazolidone and other series.

Zhejiang Limin is the third-largest manufacturer of imidazolidinone (ethylene urea) in the world, it has a market share of 5.99% in value. Zhejiang Suichang Limin Technology Co., Ltd is a medical intermediate manufacturer which is located in a beautiful city—Suichang County, Zhejiang Province, China.

Shanxi Xintianyuan is the fourth largest manufacturer of imidazolidinone (ethylene urea) in the world, it has a market share of 4.43% in value. It is a high-tech manufacturing enterprise that specializes in producing pharmaceutical intermediates.